CEO, EpiMinder

Dr Rohan Hoare

Role	Organisation	Sources
CEO	EpiMinder	Startup Daily (2 Dec 2025), SmartCompany, Startup Daily (15 Mar 2022)

Coverage

Stories naming Dr Rohan Hoare. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Exit / M&A

Epilepsy device-maker Epiminder lists on the ASX with $290 million market cap

Medical device firm Epiminder has joined the ASX, its shares dipping below issue price on debut, with the $125 million IPO proceeds earmarked for an American launch of its implantable epilepsy monitoring system next year.

SmartCompany 2 Dec 2025 Bionics Institute Cochlear EpiMinder St Vincent’s Hospital Melbourne University of Melbourne Professor Mark Cook Dr Rohan Hoare

Also Startup Daily

Bridge / extension $16m

Cochlear backs medtech startup EpiMinder in $16 million bridge funding round

Epi-Minder has completed a $16 million bridge round with its existing shareholders to fund expanded clinical trials, product development and manufacturing of its long-term epilepsy monitoring device.

Startup Daily 15 Mar 2022 EpiMinder St. Vincent's Hospital Bionics Institute Cochlear Seer Medical University of Melbourne Professor Mark Cook Dr Rohan Hoare

Also @AuManufacturing·Startup Daily·Startup Daily

Something wrong? Tell us

Dr Rohan Hoare

Roles

Coverage

Epilepsy device-maker Epiminder lists on the ASX with $290 million market cap

Cochlear backs medtech startup EpiMinder in $16 million bridge funding round